KOD

Kodiak SciencesB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$70.00

+110.7% vs current

Most likely

Base case

50%

Probability

Target price

$42.00

+26.4% vs current

B-

Bear case

30%

Probability

Target price

$18.00

-45.8% vs current

AI sentiment snapshot

Latest data as of 2026-03-27

AI commentary

Market sentiment turned strongly positive after the March 26-27 positive topline announcement; news flow and 8-K/IR updates are now the dominant drivers of price moves [#8-K-2026-03-27] [#IR-undated]. Analysts' consensus targets remain dispersed, leaving room for re-rating if management provides a clear submission timeline [#SERP-1].

RankAlpha Sentiment AI - 2026-03-27

Open full AI memo

Evidence flagged

high-coverage report lacks a dated company-specific catalyst beyond generic cadence

Impact

tentative

Confidence

AI events

2026-03-26eventPositive topline announced from GLOW2 Phase 3 (market-moving press release / 8-K)High impact

Kodiak announced positive topline results for the GLOW2 second Phase 3 study in diabetic retinopathy on March 26-27, 2026 (company press release / 8-K) — immediate commercial/regulatory implications to be disclosed in follow-up filings [#8-K-2026-03-27] [#IR-undated].

2026-06-25catalystUpcoming quarterly / investor update to quantify commercial readiness and cash runwayHigh impact

Next quarterly results / investor update should disclose updated cash runway and commercial preparations tied to the GLOW program; use the company's 10-Q / IR schedule to monitor [#10-Q-2025-11-13] [#10-K-2025-03-27].

2027-03-27catalystRegulatory pathway and potential filing (NDA/BLA) decision following GLOW2 toplineHigh impact

Management is expected to outline next regulatory steps (e.g., planned submission timing or End-of-Phase-2/3 meeting) after the GLOW2 topline; monitoring planned 8-K/IR updates and upcoming investor communications for a formal submission timeline [#8-K-2026-03-27] [#IR-undated].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-03-27 • Updated nightlySource: Internal modelMethodology